Metastatic NSCLC: A Peer-to-Peer Focus

<乌鸦传媒 class="page_title">Metastatic NSCLC: A Peer-to-Peer Focus

<乌鸦传媒>

<乌鸦传媒 class="article_title"> Metastatic NSCLC: Why and How to Standardize Biomarker Testing

This study demonstrated that implementing a standardized approach to biomarker testing, including provider education, EHR templates, and order sets, increased comprehensive biomarker testing rates in a community oncology practice setting.

<乌鸦传媒 class="article_title"> Time Toxicity in NSCLC: Understanding Healthcare Contact Days for Patients

Investigators found that patients with stage IV non鈥搒mall cell lung cancer spend, on average, approximately 30% of their 3.5 months of survival time with healthcare contact outside of the home.

<乌鸦传媒 class="article_title"> Predicting NSCLC Outcomes: The Role of Body Composition Metrics

Automated extraction of body composition parameters from computed tomography images, using deep learning, showed that loss of skeletal muscle mass was associated with worse outcomes in patients being treated with systemic therapy for advanced NSCLC.

<乌鸦传媒 class="article_title"> Exon 20 Insertion in NSCLC: How Do Patients Fare?

Using ASCO data, investigators assessed patient characteristics, treatment patterns, and outcomes among patients with EGFR exon 20-mutated non-small cell lung cancer.

乌鸦传媒

Sections